Clinical weight loss trial for nutraceutical company
In a 4-week clinical trial, the group using Maximum Slim lost an average of 3% body fat, while the placebo group averaged less than 0.5% body fat.
19/05/05 Martin Nutraceuticals Inc. has announced the initial results of a clinical trial for weight loss using a proprietary formula, Maximum Slim, developed by nutritional researcher Dr. A. W. Martin for Martin Nutraceuticals Inc.
In this 4-week clinical trial, half the patients were given 6 Maximum Slim capsules – two with every meal, and the other half were given a placebo. The group using Maximum Slim lost an average of 3% body fat, while the placebo group averaged less than 0.5% body fat.
Maximum Slim is an all natural dietary supplement consisting of proprietary herbs and nutraceuticals that stimulate fat loss by binding fat, suppressing hunger and boosting metabolism, all with no stimulants and no known side effects.
"We are very excited about the possibilities that lie in the weight loss industry," states Dr. A.W. Martin, "The weight loss industry itself is a market that is approximately $100 billion in size, effectively stating that people are conscious about the way they look and want to maintain a healthy lifestyle; Maximum Slim helps achieve this."
Upcoming webinars
The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis
From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot
Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients
